RKDA - Arcadia Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
1,197
1,464
4,026
3,188
5,414
Cost of Revenue
554
661
283
895
892
Gross Profit
643
803
3,743
2,293
4,522
Operating Expenses
Research Development
6,932
6,069
7,407
8,663
8,966
Selling General and Administrative
13,457
11,604
10,651
12,250
11,119
Total Operating Expenses
20,389
17,673
18,058
20,913
20,085
Operating Income or Loss
-19,746
-16,870
-14,315
-18,620
-15,563
Interest Expense
3
0
747
1,319
2,658
Total Other Income/Expenses Net
-3,461
3,400
-619
340
291
Income Before Tax
-23,210
-13,470
-15,681
-19,599
-17,930
Income Tax Expense
-2
10
26
25
26
Income from Continuing Operations
-23,208
-13,480
-15,707
-19,624
-17,956
Net Income
-23,208
-13,480
-15,707
-19,624
-17,956
Net Income available to common shareholders
-23,208
-13,480
-15,707
-19,624
-20,727
Reported EPS
Basic
-
-3.58
-7.28
-8.80
-14.60
Diluted
-
-3.58
-7.28
-8.80
-14.60
Weighted average shares outstanding
Basic
-
3,766
2,156
2,218
1,428
Diluted
-
3,766
2,156
2,218
1,428
EBITDA
-
-13,316
-14,655
-17,976
-14,978